Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada flag Canada · Delayed Price · Currency is CAD
0.1700
0.00 (0.00%)
Aug 28, 2026, 3:59 PM EST

Voyageur Pharmaceuticals Financials Overview

Millions CAD. Fiscal year is Dec - Nov.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Revenue
0.050.01----
Revenue Growth
------
Gross Profit
------
Operating Income
-3.3-2.89-1.51-1.22-1.61-1.97
Net Income
-3.8-3.53-1.71-1.4-1.75-2.05
Earnings Per Share
-0.02-0.02-0.01-0.01-0.02-0.02
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Investments
0.440.270.170.010.040.82
Total Debt
0.040.040.060.040.030.04
Net Cash (Debt)
0.40.230.11-0.030.010.78
Net Cash Growth
18.00%104.70%---98.46%-
Net Cash Per Share
0.000.000.00-0.000.000.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Cash Flow
-1.3-2.89-0.3-0.99-1.72-1.65
Capital Expenditures
-0.27-0.27-0.17-0.17-0.28-0.44
Free Cash Flow
-1.57-3.16-0.47-1.17-2-2.09
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Margin
-6983.18%-24758.85%----
Pretax Margin
-8033.95%-30231.56%----
Profit Margin
-8033.95%-30231.56%----
FCF Margin
-3319.15%-27067.31%----

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
814.542443.31----